Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$871,984
-$1,150,449 QoQ
Shares Held
2,408
-58.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,790
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Wealth Management LLC holds $79,224,350 across 11 Drug Manufacturers - General names. AMGN ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,177 | $37,394,632 | |
| 2 | JNJ |
Johnson & Johnson
|
118,126 | $30,000,460 | |
| 3 | ABBV |
AbbVie Inc.
|
15,919 | $4,005,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,811 | $2,674,213 | |
| 5 | PFE |
Pfizer Inc
|
65,212 | $1,570,304 | |
| 6 | AMGN |
Amgen Inc
This page
|
2,408 | $871,984 | |
| 7 | AZN |
Astrazeneca PLC
|
4,208 | $797,920 | |
| 8 | NVS |
Novartis AG
|
4,898 | $767,614 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $871,984 | 2,408 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $2,022,433 | 5,748 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,898,725 | 5,801 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,640,428 | 5,813 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $687,415 | 2,462 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $803,175 | 2,578 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $640,913 | 2,459 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $774,915 | 2,405 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $583,344 | 1,867 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $539,070 | 1,896 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $567,687 | 1,971 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $528,113 | 1,965 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $392,309 | 1,767 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $435,150 | 1,800 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $478,530 | 1,822 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $401,888 | 1,783 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $433,803 | 1,783 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $452,928 | 1,873 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $741,951 | 3,298 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,074,733 | 5,054 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,329,412 | 5,454 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,043,011 | 4,192 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $924,508 | 4,021 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,313,498 | 5,168 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,236,613 | 5,243 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $859,169 | 4,238 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||